Overactive Bladder News and Research RSS Feed - Overactive Bladder News and Research

Overactive bladder (OAB) is a urological condition defined by a set of symptoms: "urgency, with or without urge incontinence, usually with frequency and nocturia."
Gene variants linked to overactive bladder and prolapse in women

Gene variants linked to overactive bladder and prolapse in women

A systematic review and meta-analysis of genetic association studies reveals a number of genetic variations associated with overactive bladder and pelvic organ prolapse in women. [More]
NGS issues positive coverage decision for PTNS to manage symptoms of OAB

NGS issues positive coverage decision for PTNS to manage symptoms of OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014. [More]
Sacral magnetic stimulation effective in refractory stress incontinence

Sacral magnetic stimulation effective in refractory stress incontinence

Sacral magnetic stimulation may be an effective treatment for stress urinary incontinence in women whose symptoms are refractory to standard therapies, a clinical trial suggests. [More]

Urgency Questionnaire validated for use in overactive bladder

The symptom of urinary urgency experienced by people with overactive bladder is a pathological sensation distinctive from the normal urge to void, US researchers believe. [More]
Nocturia affects one in three premenopausal women

Nocturia affects one in three premenopausal women

Nocturia affects around one-third of women of reproductive age, a survey has found, highlighting that the condition is not confined to elderly individuals. [More]
LUTS highly prevalent in western Turkish population

LUTS highly prevalent in western Turkish population

Researchers have published the first-ever estimate of the prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in the population of western Turkey. [More]
Metabolic syndrome components may influence LUTS/BPH

Metabolic syndrome components may influence LUTS/BPH

Abdominal aortic calcification and visceral fat obesity each seem to influence lower urinary tract symptoms in men with benign prostatic hyperplasia, study findings suggest. [More]

OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

There is considerable overlap between symptoms in patients with interstitial cystitis/bladder pain syndrome and those with overactive bladder, US researchers have shown. [More]
TENS effective for poststroke urinary incontinence

TENS effective for poststroke urinary incontinence

Transcutaneous electrical nerve stimulation is effective for improving symptoms and enhancing quality of life in people who develop incontinence following a stroke, research suggests. [More]
First morning voided volume useful for OAB evaluation

First morning voided volume useful for OAB evaluation

Measuring the first morning voided volume may be helpful for evaluating symptom severity in patients with overactive bladder, researchers believe. [More]

Prolapse repair fails to improve sling outcomes in OAB patients

Performing concomitant anterior compartment repair in women receiving a midurethral sling for overactive bladder does not seem to offer any additional benefit, results of a cohort study indicate. [More]

Uroplasty participates in 9th Annual JMP Securities Healthcare Conference

Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24. [More]
Urinary symptom screening tool validated for female OAB

Urinary symptom screening tool validated for female OAB

The Actionable Bladder Symptom Screening Tool is a reliable, valid and sensitive instrument in women with incontinence due to non-neurogenic overactive bladder, researchers report. [More]
Urinary microbiota implicated in overactive bladder

Urinary microbiota implicated in overactive bladder

Contrary to popular belief, urine is not sterile and contains a range of microbiological organisms that vary in health and disease, US scientists have shown. [More]

Ring pessary for OAB as effective as nonsurgical therapies

The use of a ring pessary appears to be an effective, well tolerated and inexpensive treatment for overactive bladder, say US researchers writing in International Urogynecology Journal. [More]
Bacteria in urine could contribute to overactive bladder

Bacteria in urine could contribute to overactive bladder

Bacteria live in the bladders of healthy women, discrediting the common belief that normal urine is sterile. This finding was presented today by researchers from Loyola University Chicago at the 114th General Meeting of the American Society for Microbiology in Boston. [More]
Bacteria in urine may be associated with overactive bladder

Bacteria in urine may be associated with overactive bladder

Contrary to popular belief, urine is not sterile and the bacteria in it may be associated with overactive bladder (OAB) in some women, according to research presented today at the annual meeting of the American Society for Microbiology. [More]
Inflammation may accentuate age-related bladder function decline

Inflammation may accentuate age-related bladder function decline

Age-associated biochemical changes in the bladder may accentuate the inflammation associated with overactive bladder, study findings indicate. [More]
Pelvic floor prolapse has unclear relationship with urinary symptoms

Pelvic floor prolapse has unclear relationship with urinary symptoms

In women seeking treatment for pelvic floor problems, the severity of pelvic organ prolapse is not independently associated with lower urinary tract symptoms, a study by Spanish researchers has found. [More]
Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014. [More]